Clinical Trial Update: BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

BXCL701 is being studied in a Phase 1 trial for relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with excess blasts-2, and the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome with Excess Blasts-2

Drugs mentioned

• BXCL701

Snippet

Sponsor: Eric Stephen Winer, MD | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 | Phase 1 | Status: RECRUITING